Generic placeholder image

Recent Patents on CNS Drug Discovery (Discontinued)


ISSN (Print): 1574-8898
ISSN (Online): 2212-3954

Implication of Possible Therapies Targeted for the Tachykinergic System with the Biology of Neurokinin Receptors and Emerging Related Proteins

Author(s): Pranela Rameshwar

Volume 2, Issue 1, 2007

Page: [79 - 84] Pages: 6

DOI: 10.2174/157488907779561781

Price: $65


The neurokinin (NK) receptor family has been proposed as targets for neural-related diseases. The experimental studies indicate that this family of receptors might also be targets for malignancies, both solid and hematological tumors. However, an understanding of the biology of other rmolecules with sequence similarity to NK receptors is required. Of significance is the HGFIN gene that shares structural homology with NK1. Through this homology, the HGFIN interacts with the high affinity ligand of NK1, substance P. This report discusses potential applications for targets against NK receptors, and the role of HGFIN in drug designs. This review is relevant for central and peripheral nervous system drug development, and also cancer drugs for breast and neuroblastoma. The potential for leukemia drugs and Patents are also discussed

Keywords: Bone marrow, neurokinin receptors, HGFIN, cytokines, neurotransmitters, tachykinins, hematopoiesis, nmb, substance P, neurokinin-A

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy